Dysregulation of TGF-β signaling, frequently occurring in pre-malignant and malignant lesions of the gastrointestinal tract, appears to have a substantial impact on the immune microenvironment that may in turn impact tumorigenesis and tumor progression through altered immune cell recruitment (Figure 1). This evidence concerns the gene TGFB1 and neoplasm.